Collegium Pharmaceutical announces redemption of convertible senior notes

Collegium Pharmaceutical has called all $26,350,000 aggregate principal amount of its outstanding 2.625% Convertible Senior Notes Due 2026 for redemption on Friday, June 14, 2024. The redemption price will be payable in cash and equal to 100% of the principal amount of each Note called for redemption, plus accrued and unpaid interest on each such Note to, but excluding, the Redemption Date. For each $1,000 principal amount of Notes, the Redemption Price is equal to approximately $1,008.68. The Company’s redemption right in respect of the Notes arises pursuant to Section 4.03(B) of the indenture governing the Notes as a result of the last reported sale price of the Company’s common stock exceeding 130% of the conversion price of the Notes during the required period of time. Payment of the Redemption Price will be made upon presentation and surrender of the Notes to The Bank of New York Mellon Trust Company, N.A., in its capacity as paying agent under the Indenture at the following address: The Bank of New York Mellon Trust Company, N.A., 2001 Bryan Street, 10th Floor, Dallas, Texas 75201, Attention: Transfers/Redemption/Payments. Notes held through The Depository Trust Company should be presented and surrendered for redemption in accordance with DTC’s policies and procedures therefor.